AcuCort receives trademark protection for Zeqmelit® in Switzerland
AcuCort AB announces that the trademark for the company's medication Zeqmelit® has been registered for trademark protection in Switzerland.The trademark protection is strategically important as the company enters its commercialization phase. "It is very gratifying that we have now obtained trademark protection in Switzerland for our oral film Zeqmelit® with its associated areas of use. It is an important step towards commercialization in Switzerland," says AcuCort's CEO Jonas Jönmark. The trademark protection for Zeqmelit® in Switzerland is valid for the next 10 years, after which the